Concepedia

José-Luis López-Zaragoza

JL

Statistics

Publications

3

Citations

412

H-Index

3

Active since

2017

Affiliations

Inserm(Current)

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Hôpital Albert-Chenevier

Hôpital Cochin

José-Luis López-Zaragoza is an author at Inserm specializing in infectious diseases, molecular virology, and atherosclerosis risk.

Publications per year

2017–2020

3

Publications

3

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

Benjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza et al. · Nature · 2017 · 232 citations

, , +14

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

, , +14

Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus

Boun Kim Tan, Mathieu Chalouni, Dominique Salmon Ceron et al. · Clinical Infectious Diseases · 2020 · 10 citations · Full text

, , +16

1–3 of 3